首页> 外文OA文献 >Same patient, new stone composition: amprenavir urinary stone
【2h】

Same patient, new stone composition: amprenavir urinary stone

机译:同一患者,新结石成分:安普那韦尿路结石

摘要

We report here the first case to add amprenavir to the growing list of antiretroviral drugs associated with urinary stones. The first reported case of a nelfinavir urinary stone was reported in 2002 in a 37-year-old HIV-infected woman. In September 2007, the same female patient was referred to our department with recent onset of right flank pain and recurrent urinary tract infections. Abdominal computed tomography revealed three obstructing stones in the distal right ureter, another stone in the right renal pelvis with hydronephrosis and a stone in the left kidney. After stone retrieval, analysis of the stone by liquid chromatography with mass spectrometry revealed a stone composition of 95% unmodified amprenavir and 5% ritonavir.
机译:我们在此报告了第一个将氨普那韦添加到与尿结石相关的抗逆转录病毒药物的清单中的第一个案例。 2002年,首例报道了奈非那韦泌尿系结石的病例是一名37岁的HIV感染妇女。 2007年9月,同一名女性患者因近期出现右胁腹疼痛和尿路反复感染而被转诊至我科。腹部计算机断层扫描显示,右输尿管远端有三处阻塞性结石,右肾​​盂积水有肾结石,左肾有结石。取石后,通过质谱与液相色谱法对宝石进行分析,结果发现宝石成分为95%未修饰的氨普那韦和5%利托那韦。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号